Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
68,147,068
-
Share change
-
+7,021,567
-
Total reported value
-
$7,437,079,479
-
Put/Call ratio
-
66%
-
Price per share
-
$109.13
-
Number of holders
-
322
-
Value change
-
+$732,785,812
-
Number of buys
-
164
-
Number of sells
-
161
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2018
As of 31 Dec 2018,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
322 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,147,068 shares.
The largest 10 holders included
FMR LLC, Vanguard Group Inc, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, SANDS CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, FRED ALGER MANAGEMENT INC, FIL Ltd, and venBio Select Advisor LLC.
This page lists
323
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.